EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease

Madhura Chandrashekar, Gowshika Velmurugan, Amit Mishra, Subashchandrabose Chinnathambi

Advances in Protein Chemistry and Structural Biology · 2026

DOI: 10.1016/bs.apcsb.2025.10.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2026. Verfasst von Madhura Chandrashekar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Institute of National Importance, Bangalore, Karnataka, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Antimicrobial Peptides, Brain. Die Arbeit nennt 135 Literaturangaben. Gefördert von: National Institute of Mental Health and Neurosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease is a most prevalent type of dementia in elderly people. Extracellular accumulation of Amyloid-β (Aβ) and intracellular aggregation of Tau NFTs in the brain is proposed to be a key factor in the development of Alzheimer's disease. A fast-growing body of evidence strengthened the infectious hypothesis of sporadic type of AD. Recent clinical studies focused on the characterizing of antimicrobial peptides (AMPs), because it has been documented that some pathogenic microorganism, such as herpesviruses and particular bacterial strains, are generally present in AD individuals. And also, the environmental factors, such as persistent bacterial or viral infections, change the blood-brain barrier's (BBB) permeability, making it easier for opportunistic pathogens to colonise the brain. This review highlights the potential role of Aβ, which perform antimicrobial activity against diverse pathogens, significantly encouraging its role in the innate immune response. While mammalian amyloid is linked with disease, numerous microbes form amyloid fibrils to embattle the biofilm that prevent the cells from the surrounding environment. According to the microbial AD hypothesis, Aβ clumps up to combat the microbial infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAntimicrobial PeptidesBrainHumansAmyloid beta-PeptidesAnimalsImmunity, InnateBlood-Brain Barrier

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloid-βAntimicrobial peptidesPathogensTau

Substanzen

Antimicrobial PeptidesAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Institute of National Importance, Bangalore, Karnataka, India.
  • Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India.
  • Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Institute of National Importance, Bangalore, Karnataka, India. Electronic address: subashneuro@nimhans.ac.in.

Förderung

  • National Institute of Mental Health and Neurosciences

Zitieren

APA

Chandrashekar, M., Velmurugan, G., Mishra, A., & Chinnathambi, S. (2026). Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2025.10.016

Vancouver

Chandrashekar M, Velmurugan G, Mishra A, Chinnathambi S. Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease. Advances in Protein Chemistry and Structural Biology. 2026. doi:10.1016/bs.apcsb.2025.10.016

BibTeX
@article{Chandrashekar2026,
  author = {Chandrashekar, Madhura and Velmurugan, Gowshika and Mishra, Amit and Chinnathambi, Subashchandrabose},
  title = {Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease},
  journal = {Advances in Protein Chemistry and Structural Biology},
  year = {2026},
  doi = {10.1016/bs.apcsb.2025.10.016}
}
Kostenlos starten →